TFFP
Tff Pharmaceuticals Inc (TFFP)
$5.59
Key Stats
| Open | $6.05 |
| Today Low/High | $5.59 / $6.05 |
| 52 Week Low/High | $6.29 / $20.54 |
| Market Cap | $175.83M |
Company Details
TFF Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented Thin Film Freezing, or TFF, technology platform. Early testing confirms that the TFF platform can significantly improve the solubility and absorption of poorly water-soluble drugs, a class of drugs that comprises approximately one-third of the major pharmaceuticals worldwide, thereby improving their pharmacokinetics. TFF Pharmaceuticals has two lead drug candidates: Voriconazole Inhalation Powder and Tacrolimus Inhalation Powder. The Company plans to add to this pipeline by collaborating with large pharmaceutical partners. The TFF Platform is protected by 42 patents issued or pending in the US and internationally.
| Organisation | Tff Pharmaceuticals Inc |
| Headquaters | Austin, Texas, US |
| Employees | 4 |
| Industry | Health Technology |
